• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Analyzing outcomes for peripheral versus central administration of vasopressors: A narrative review.血管升压药外周给药与中心给药的效果分析:一篇叙述性综述。
Saudi J Anaesth. 2025 Jul-Sep;19(3):375-383. doi: 10.4103/sja.sja_211_25. Epub 2025 Jun 16.
2
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
3
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
4
Automated devices for identifying peripheral arterial disease in people with leg ulceration: an evidence synthesis and cost-effectiveness analysis.用于识别下肢溃疡患者外周动脉疾病的自动化设备:证据综合和成本效益分析。
Health Technol Assess. 2024 Aug;28(37):1-158. doi: 10.3310/TWCG3912.
5
Systemic Inflammatory Response Syndrome全身炎症反应综合征
6
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
7
Vasopressors for hypotensive shock.用于低血压性休克的血管加压药。
Cochrane Database Syst Rev. 2016 Feb 15;2(2):CD003709. doi: 10.1002/14651858.CD003709.pub4.
8
Uterotonic agents for preventing postpartum haemorrhage: a network meta-analysis.预防产后出血的宫缩剂:一项网状Meta分析
Cochrane Database Syst Rev. 2018 Apr 25;4(4):CD011689. doi: 10.1002/14651858.CD011689.pub2.
9
Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation.成人癫痫新药的临床疗效、耐受性及成本效益:一项系统评价与经济学评估
Health Technol Assess. 2005 Apr;9(15):1-157, iii-iv. doi: 10.3310/hta9150.
10
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块型银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2022 May 23;5(5):CD011535. doi: 10.1002/14651858.CD011535.pub5.

本文引用的文献

1
Complication Rates of Central Venous Catheters: A Systematic Review and Meta-Analysis.中心静脉导管相关并发症发生率:系统评价和荟萃分析。
JAMA Intern Med. 2024 May 1;184(5):474-482. doi: 10.1001/jamainternmed.2023.8232.
2
Exposure to COVID-19 among unvaccinated healthcare personnel and risk for infection: a single-center retrospective study.未接种疫苗的医护人员接触 COVID-19 及其感染风险:一项单中心回顾性研究。
J Infect Dev Ctries. 2023 Aug 31;17(8):1081-1087. doi: 10.3855/jidc.17798.
3
Peripheral Administration of Norepinephrine: A Prospective Observational Study.去甲肾上腺素的外周给药:一项前瞻性观察性研究。
Chest. 2024 Feb;165(2):348-355. doi: 10.1016/j.chest.2023.08.019. Epub 2023 Aug 21.
4
Best practice in the use of peripheral venous catheters: A scoping review and expert consensus.外周静脉导管使用的最佳实践:一项范围综述与专家共识
Infect Prev Pract. 2023 Feb 3;5(2):100271. doi: 10.1016/j.infpip.2023.100271. eCollection 2023 Jun.
5
Things We Do for No Reason : Mandatory central venous catheter placement for initiation of vasopressors.我们无缘无故做的事情:为启动血管加压药而强制放置中心静脉导管。
J Hosp Med. 2022 Jul;17(7):565-568. doi: 10.1002/jhm.12844.
6
Hospital Policies on Intravenous Vasopressor Administration and Monitoring: A Survey of Michigan Hospitals.密歇根州医院静脉血管加压药使用与监测的医院政策:一项调查
Ann Am Thorac Soc. 2022 Oct;19(10):1769-1772. doi: 10.1513/AnnalsATS.202203-197RL.
7
Peripheral intravenous catheter failure: A secondary analysis of risks from 11,830 catheters.外周静脉导管失败:11830 个导管风险的二次分析。
Int J Nurs Stud. 2021 Dec;124:104095. doi: 10.1016/j.ijnurstu.2021.104095. Epub 2021 Sep 26.
8
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021.拯救脓毒症运动:2021年脓毒症和脓毒性休克国际管理指南
Crit Care Med. 2021 Nov 1;49(11):e1063-e1143. doi: 10.1097/CCM.0000000000005337.
9
Safety and efficacy of peripheral versus centrally administered vasopressor infusion: A single-centre retrospective observational study.外周与中枢血管加压素输注的安全性和有效性:一项单中心回顾性观察研究。
Aust Crit Care. 2022 Sep;35(5):506-511. doi: 10.1016/j.aucc.2021.08.005. Epub 2021 Sep 30.
10
Adverse events associated with administration of vasopressor medications through a peripheral intravenous catheter: a systematic review and meta-analysis.外周静脉导管给药时与血管加压药物相关的不良事件:系统评价和荟萃分析。
Crit Care. 2021 Apr 16;25(1):146. doi: 10.1186/s13054-021-03553-1.

血管升压药外周给药与中心给药的效果分析:一篇叙述性综述。

Analyzing outcomes for peripheral versus central administration of vasopressors: A narrative review.

作者信息

Dryden Jack, Navas-Blanco Jose

机构信息

Department of Anesthesiology, Oakland University William Beaumont School of Medicine, Corewell Health East, Royal Oak, Michigan, USA.

出版信息

Saudi J Anaesth. 2025 Jul-Sep;19(3):375-383. doi: 10.4103/sja.sja_211_25. Epub 2025 Jun 16.

DOI:10.4103/sja.sja_211_25
PMID:40642641
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12240503/
Abstract

There is an emerging body of evidence to suggest that the peripheral administration of vasopressors is safe and effective in many clinical contexts and often superior to central administration. Vasopressors are a class of medications used to create vasoconstriction in patients with shock to increase systemic arterial blood pressure and tissue perfusion. Certain clinical circumstances require the use of these vasoactive drugs immediately for which the need to administer these drugs peripherally becomes paramount, although controversial. The authors present a narrative review dedicated to describing the current practice of the route of administration of vasopressors, comparing peripheral versus central administration, and explaining the advantages and drawbacks of each route as well as potential complications associated with them.

摘要

越来越多的证据表明,在许多临床情况下,外周给予血管升压药是安全有效的,而且往往优于中心给药。血管升压药是一类用于使休克患者血管收缩以提高体循环动脉血压和组织灌注的药物。某些临床情况需要立即使用这些血管活性药物,尽管存在争议,但在外周给予这些药物的必要性变得至关重要。作者进行了一项叙述性综述,专门描述血管升压药给药途径的当前实践,比较外周给药与中心给药,并解释每种途径的优缺点以及与之相关的潜在并发症。